Articles Tagged With:
-
Is It a Problem to Pay Research Participants?
Paying people to participate in clinical research can be seen as ethically problematic. Yet community members expressed the opposite view, according to the results of a recent study.
-
Changing Practice Models in Healthcare Raise Some Ethical Concerns
With all the ongoing changes in healthcare, such as physician contract clauses, new regulatory requirements, private equity ownership, and physician leadership, hospitals worry about the implications on revenue, patient satisfaction, and compliance. There also are important ethical considerations. The authors of a new policy paper from the American College of Physicians examined these.
-
Policies Support Clinicians if Asked to Provide Inappropriate Care
When a family demands possibly inappropriate life-sustaining interventions, clinicians often turn to hospital policies for guidance. The authors of a recent study examined the effectiveness of Yale New Haven Hospital’s Conscientious Practice Policy. A theme emerged, focused on the inconsistent use of the policy. Whether it was used depended mostly on how resistant the family was to limiting interventions.
-
Dasiglucagon Injection (Zegalogue)
Dasiglucagon should be prescribed to treat severe hypoglycemia in pediatric and adult patients (≥ age 6 years).
-
Herpes Zoster Vaccine: Effective but Underused
The adjuvanted recombinant herpes zoster vaccine is highly effective in practice, but it is vastly underused.
-
Antibiotics: Less Is Better, Sometimes
In England, and likely in many other areas of the world, antibiotics are given for longer than necessary. Excessively long durations of antibiotic use do not help patients and risk leading to more resistant infections.
-
Is Empagliflozin Safe in Combination with a Neprilysin Inhibitor for Heart Failure?
A prespecified subgroup analysis of heart failure patients with reduced ejection fraction who were on neprilysin inhibitors before empagliflozin was administered (vs. those not on neprilysin inhibitors) showed the reduction in mortality and hospital admissions for heart failure was not attenuated by concurrent neprilysin use.
-
Accounting for Patient Preference, Cardiovascular Disease Risk in Statin Therapy
Researchers weighed patient preferences and risks regarding statin therapy after reviewing 10-year atherosclerotic cardiovascular disease risk scores.
-
Is Metformin a Wonder Drug?
An analysis of patients taking metformin for diabetes showed they were less likely to report back, knee, neck/shoulder, or multisite musculoskeletal pain.
-
Study Reveals Increased IUD Expulsion Rate After Vaginal Delivery
Physicians sometimes worry that women who have not given birth will have more difficulty with an intrauterine device, experiencing a higher expulsion rate. But the results of a recent study show that the opposite is true.